Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Gender difference in long-term prognosis among patients with cardiovascular disease.

van der Meer MG, Cramer MJ, van der Graaf Y, Doevendans PA, Nathoe HM; (on behalf of the SMART study group).

Eur J Prev Cardiol. 2014 Jan;21(1):81-9. doi: 10.1177/2047487312460519. Epub 2012 Sep 5.

PMID:
22952288
2.

Self-rated health status as a risk factor for future vascular events and mortality in patients with symptomatic and asymptomatic atherosclerotic disease: the SMART study.

Grool AM, van der Graaf Y, Visseren FL, de Borst GJ, Algra A, Geerlings MI; SMART Study Group.

J Intern Med. 2012 Sep;272(3):277-86. doi: 10.1111/j.1365-2796.2012.02521.x. Epub 2012 Feb 26.

3.

The impact of polyvascular disease on long-term outcome in percutaneous coronary intervention patients.

van der Meer MG, Cramer MJ, van der Graaf Y, Appelman Y, Doevendans PA, Nathoe HM; SMART Study Group.

Eur J Clin Invest. 2014;44(3):231-9. doi: 10.1111/eci.12222. Epub 2013 Dec 27.

PMID:
24372467
4.

Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study.

Achterberg S, Cramer MJ, Kappelle LJ, de Borst GJ, Visseren FL, van der Graaf Y, Algra A; SMART study Group.

Eur J Cardiovasc Prev Rehabil. 2010 Aug;17(4):424-30. doi: 10.1097/HJR.0b013e3283361ce6.

PMID:
20555265
5.

Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.

van den Berg MJ, van der Graaf Y, de Borst GJ, Kappelle LJ, Nathoe HM, Visseren FLJ; SMART Study Group.

Am J Cardiol. 2016 Sep 15;118(6):804-810. doi: 10.1016/j.amjcard.2016.06.048. Epub 2016 Jun 28.

6.

High aortic augmentation index predicts mortality and cardiovascular events in men from a general population, but not in women.

Janner JH, Godtfredsen NS, Ladelund S, Vestbo J, Prescott E.

Eur J Prev Cardiol. 2013 Dec;20(6):1005-12. doi: 10.1177/2047487312449588. Epub 2012 May 30.

PMID:
22649125
7.

Prediction model with metabolic syndrome to predict recurrent vascular events in patients with clinically manifest vascular diseases.

Wassink AM, van der Graaf Y, Janssen KJ, Cook NR, Visseren FL; SMART Study Group.

Eur J Prev Cardiol. 2012 Dec;19(6):1486-95. doi: 10.1177/1741826711426636. Epub 2011 Oct 18.

PMID:
22008749
8.

Effect of Type 2 Diabetes on Recurrent Major Cardiovascular Events for Patients With Symptomatic Vascular Disease at Different Locations.

Stam-Slob MC, van der Graaf Y, de Borst GJ, Cramer MJ, Kappelle LJ, Westerink J, Visseren FL; SMART Study Group.

Diabetes Care. 2015 Aug;38(8):1528-35. doi: 10.2337/dc14-2900. Epub 2015 Jun 2.

PMID:
26038582
9.

The impact of gender on prognosis after non-cardiac vascular surgery.

Grootenboer N, Hunink MG, Hoeks S, Hendriks JM, van Sambeek MR, Poldermans D.

Eur J Vasc Endovasc Surg. 2011 Oct;42(4):510-6. doi: 10.1016/j.ejvs.2011.06.029. Epub 2011 Jul 26.

10.

Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study.

Leening MJ, Ferket BS, Steyerberg EW, Kavousi M, Deckers JW, Nieboer D, Heeringa J, Portegies ML, Hofman A, Ikram MA, Hunink MG, Franco OH, Stricker BH, Witteman JC, Roos-Hesselink JW.

BMJ. 2014 Nov 17;349:g5992. doi: 10.1136/bmj.g5992.

11.

Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.

Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.

Res Rep Health Eff Inst. 2009 Mar;(139):5-71; discussion 73-89.

PMID:
19554969
12.

Relation between thyroid-stimulating hormone and the occurrence of cardiovascular events and mortality in patients with manifest vascular diseases.

Westerink J, van der Graaf Y, Faber DR, Spiering W, Visseren FL; SMART study group.

Eur J Prev Cardiol. 2012 Aug;19(4):864-73. doi: 10.1177/1741826711416045. Epub 2011 Jul 1.

PMID:
21724680
13.

Gender differences in stroke risk among the elderly after coronary artery surgery.

Goto T, Baba T, Ito A, Maekawa K, Koshiji T.

Anesth Analg. 2007 May;104(5):1016-22, tables of contents.

PMID:
17456646
14.

Socioeconomic inequalities in cardiovascular mortality and the role of childhood socioeconomic conditions and adulthood risk factors: a prospective cohort study with 17-years of follow up.

Kamphuis CB, Turrell G, Giskes K, Mackenbach JP, van Lenthe FJ.

BMC Public Health. 2012 Dec 5;12:1045. doi: 10.1186/1471-2458-12-1045.

15.

Aldosterone, atherosclerosis and vascular events in patients with stable coronary artery disease.

Hillaert MA, Lentjes EG, Kemperman H, van der Graaf Y, Nathoe HM, Beygui F, Montalescot G, Doevendans PA, Wassink AM, van Belle E; SMART Study Group.

Int J Cardiol. 2013 Sep 1;167(5):1929-35. doi: 10.1016/j.ijcard.2012.05.034. Epub 2012 Jun 23.

16.

The relation between the presence of cardiovascular disease and vascular risk factors in offspring and the occurrence of new vascular events in their parents already at high vascular risk.

Weijmans M, van der Graaf Y, de Borst GJ, Asselbergs FW, Cramer MJ, Algra A, Visseren FL; SMART study group.

Am Heart J. 2015 Oct;170(4):744-752.e2. doi: 10.1016/j.ahj.2015.06.023. Epub 2015 Jul 3.

PMID:
26386798
17.

Comparison of prognosis in unrecognized versus recognized myocardial infarction in men versus women >55 years of age (from the Rotterdam Study).

Dehghan A, Leening MJ, Solouki AM, Boersma E, Deckers JW, van Herpen G, Heeringa J, Hofman A, Kors JA, Franco OH, Ikram MA, Witteman JC.

Am J Cardiol. 2014 Jan 1;113(1):1-6. doi: 10.1016/j.amjcard.2013.09.005. Epub 2013 Oct 2.

PMID:
24216125
18.

Preoperative cardiac risk index predicts long-term mortality and health status.

Hoeks SE, op Reimer WJ, van Gestel YR, Smolderen KG, Verhagen H, van Domburg RT, van Urk H, Poldermans D.

Am J Med. 2009 Jun;122(6):559-65. doi: 10.1016/j.amjmed.2008.10.041. Epub 2009 Apr 18.

PMID:
19376487
19.

Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease.

Welten GM, Schouten O, Hoeks SE, Chonchol M, Vidakovic R, van Domburg RT, Bax JJ, van Sambeek MR, Poldermans D.

J Am Coll Cardiol. 2008 Apr 22;51(16):1588-96. doi: 10.1016/j.jacc.2007.11.077.

20.

Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease.

de Vos LC, Mulder DJ, Smit AJ, Dullaart RP, Kleefstra N, Lijfering WM, Kamphuisen PW, Zeebregts CJ, Lefrandt JD.

Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):933-8. doi: 10.1161/ATVBAHA.113.302731. Epub 2014 Feb 13.

Supplemental Content

Support Center